CHINET 2009 surveillance of antimicrobial resistance in Pseudomonas aeruginosa in China

Chinese Journal of Infection and Chemotherapy

Volumn 10, Issue 6, 2010, Pages 436-440

  Zhang, Yibo ^a   Ni, Yuxing ^a   Sun, Jingyong ^a   Zhu, Demei ^a   Hu, Fupin ^a   Wang, Fu ^a   Jiang, Xiaofei ^a   Yu, Yunsong ^a   Yang, Qing ^a   Sun, Ziyong ^a   Jian, Cui ^a   Xu, Yingchun ^a   Sun, Hongli ^a   Hu, Yunjian ^a   Xiaoman, Al ^a   Shan, Bin ^a   Du, Yan ^a   Su, Danhong ^a   Zhuo, Chao ^a   Xu, Yuanhong ^a   Shen, Jilu ^a   Wang, Chuanqing ^a   Wang, Aimin ^a   Jia, Bei ^a   Huang, Wenxiang ^a   Wei, Lianhua ^a   Wu, Ling ^a   Zhang, Chaoxia ^a   Ji, Ping ^a   Zhang, Hong ^a   Li, Wanhua ^a   more..

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antimicrobial agent; Antimicrobial resistance; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CHINA; DATA ANALYSIS; DATA ANALYSIS SOFTWARE; DRUG SURVEILLANCE PROGRAM; HOSPITAL; HOSPITAL PATIENT; INTENSIVE CARE UNIT; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM;

EID: 78649965127     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Sixteenth informational supplement, 2009,M100-S16.
2. Biedenbach DJ, Moet GJ, Jones RN. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program(1997-2002)[J]. Diagn Microbiol Infect Dis, 2004, 50(1):59-69.
3. Gaynes R, Edwards JR. National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by Gram-negative bacilli[J]. Clin Infect Dis, 2005, 41 (6) : 848-854.
4. Walkty A, Decorby M, Nichol K, et al. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study[J]. Diagn Microbiol Infect Dis, 2008,61(2) :217-221.
5. Corona-Nakamura AL, Miranda-Novales MG, Leanos-Miranda B, et al. Epidemiologic Study of Pseudomonas aeruginosa in critical patients and reservoirs[J]. Arch Med Res,2001,32 (3):238-242.